Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Smilek

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cell|October 20, 1989
Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapyD C Wraith, D E Smilek, D J Mitchell, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1989
Evolution, function, and utilization of major histocompatibility complex polymorphism in autoimmune diseaseH O McDevitt, D C Wraith, D E Smilek, et al.
International Reviews of Immunology|January 1, 1990
T cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptidesD C Wraith, D E Smilek, D J Mitchell, et al.
Immunogenetics|January 1, 1981
Monoclonal rat anti-MHC alloantibodies detect HLA-linked polymorphisms in humansH C Boyd, D E Smilek, R S Spielman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1991
A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitisD E Smilek, D C Wraith, S Hodgkinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunityA M Gautam, C B Lock, D E Smilek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1992
Inhibition of experimental autoimmune encephalomyelitis by a nonimmunogenic non-self peptide that binds to I-AuA M Gautam, C I Pearson, A A Sinha, et al.
The Journal of Experimental Medicine|May 1, 1980
Monoclonal rat anti-major histocompatibility complex antibodies display specificity for rat, mouse, and human target cellsD E Smilek, H C Boyd, D B Wilson, et al.
Blood|October 15, 1994
Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex moleculesP G Schlegel, R Aharoni, D E Smilek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1998
Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptideE A Leadbetter, C R Bourque, B Devaux, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell|October 20, 1989
Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapyD C Wraith, D E Smilek, D J Mitchell, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1989
Evolution, function, and utilization of major histocompatibility complex polymorphism in autoimmune diseaseH O McDevitt, D C Wraith, D E Smilek, et al.
International Reviews of Immunology|January 1, 1990
T cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptidesD C Wraith, D E Smilek, D J Mitchell, et al.
Immunogenetics|January 1, 1981
Monoclonal rat anti-MHC alloantibodies detect HLA-linked polymorphisms in humansH C Boyd, D E Smilek, R S Spielman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1991
A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitisD E Smilek, D C Wraith, S Hodgkinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunityA M Gautam, C B Lock, D E Smilek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1992
Inhibition of experimental autoimmune encephalomyelitis by a nonimmunogenic non-self peptide that binds to I-AuA M Gautam, C I Pearson, A A Sinha, et al.
The Journal of Experimental Medicine|May 1, 1980
Monoclonal rat anti-major histocompatibility complex antibodies display specificity for rat, mouse, and human target cellsD E Smilek, H C Boyd, D B Wilson, et al.
Blood|October 15, 1994
Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex moleculesP G Schlegel, R Aharoni, D E Smilek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1998
Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptideE A Leadbetter, C R Bourque, B Devaux, et al.
Pageof 2